Glatiramer acetate treatment negatively regulates type I interferon signalingNicolas Molnarfi(University Hospital of Geneva), Scott S. Zamvil(University of California, San Francisco)Neurology Neuroimmunology & NeuroinflammationNovember 10, 201510.1212/nxi.0000000000000179Cited by 18SaveCiteExport RISWatch citationsRelated PapersLaquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity|PLoS ONE|2012|97Opposite Regulation of IL-1β and Secreted IL-1 Receptor Antagonist Production by Phosphatidylinositide-3 Kinases in Human Monocytes Activated by Lipopolysaccharides or Contact with T Cells|The Journal of Immunology|2007|51